Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free NOEMW Stock Alerts

Noema Pharma (NOEMW) Competitors

Noema Pharma logo
$0.10 -0.01 (-9.55%)
As of 05/29/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NOEMW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Noema Pharma stock or one of its competitors? MarketBeat compares Noema Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Noema Pharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Noema Pharma compare to 60 Degrees Pharmaceuticals?

Noema Pharma (NASDAQ:NOEMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

In the previous week, Noema Pharma had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for Noema Pharma and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Noema Pharma's score of 1.43 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Noema Pharma Positive
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Noema Pharma (NASDAQ:NOEMW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 2 articles in the media. Noema Pharma's average media sentiment score of 1.43 beat Alpha Tau Medical's score of 0.43 indicating that Noema Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Noema Pharma Positive

Summary

Noema Pharma beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to Apollomics?

Noema Pharma (NASDAQ:NOEMW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Noema Pharma had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for Noema Pharma and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Noema Pharma's score of 1.43 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
Noema Pharma Positive
Apollomics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Summary

Apollomics beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to BioVie?

Noema Pharma (NASDAQ:NOEMW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, Noema Pharma and Noema Pharma both had 2 articles in the media. Noema Pharma's average media sentiment score of 1.43 beat BioVie's score of 0.44 indicating that Noema Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Noema Pharma Positive
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
BioVie N/A N/A N/A

Summary

Noema Pharma beats BioVie on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to Cardio Diagnostics?

Noema Pharma (NASDAQ:NOEMW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

In the previous week, Noema Pharma had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 2 mentions for Noema Pharma and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.87 beat Noema Pharma's score of 1.43 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
Noema Pharma Positive
Cardio Diagnostics Very Positive

Summary

Cardio Diagnostics beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

Get Noema Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOEMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOEMW vs. The Competition

Export
MetricNoema PharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$381.57M$6.44B$12.61B
Dividend YieldN/A3.86%2.69%5.24%
P/E RatioN/A3.1321.4126.29
Price / SalesN/A7,202.70530.6093.62
Price / CashN/A13.1343.6557.38
Price / BookN/A85.4810.607.32
Net IncomeN/A-$96.07M$3.56B$337.27M
7 Day PerformanceN/A2.07%2.85%3.58%
1 Month PerformanceN/A2.87%4.58%5.71%
1 Year PerformanceN/A96.42%37.67%39.75%

Noema Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOEMW
Noema Pharma
N/A$0.10
-8.2%		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
flat		N/A-36.0%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.54
-0.8%		N/A+1,020.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-1.4%		N/A-46.2%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.32
+1.6%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NOEMW) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners
President Trump just sparked a stock market MELT UP
The real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...
Stansberry Research | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel